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A new live-cell reporter strategy 
to simultaneously monitor 
mitochondrial biogenesis and 
morphology
Linn Iren Hodneland  Nilsson1,*, Ina Katrine Nitschke Pettersen1,*, Julie Nikolaisen1, 
David Micklem2, Hege Avsnes Dale3, Gro Vatne Røsland1, James Lorens1 & Karl 
Johan Tronstad1
Changes in mitochondrial amount and shape are intimately linked to maintenance of cell 
homeostasis via adaptation of vital functions. Here, we developed a new live-cell reporter strategy 
to simultaneously monitor mitochondrial biogenesis and morphology. This was achieved by making a 
genetic reporter construct where a master regulator of mitochondrial biogenesis, nuclear respiratory 
factor 1 (NRF-1), controls expression of mitochondria targeted green fluorescent protein (mitoGFP). 
HeLa cells with the reporter construct demonstrated inducible expression of mitoGFP upon activation 
of AMP-dependent protein kinase (AMPK) with AICAR. We established stable reporter cells where 
the mitoGFP reporter activity corresponded with mitochondrial biogenesis both in magnitude and 
kinetics, as confirmed by biochemical markers and confocal microscopy. Quantitative 3D image 
analysis confirmed accordant increase in mitochondrial biomass, in addition to filament/network 
promoting and protecting effects on mitochondrial morphology, after treatment with AICAR. The 
level of mitoGFP reversed upon removal of AICAR, in parallel with decrease in mtDNA. In summary, 
we here present a new GFP-based genetic reporter strategy to study mitochondrial regulation and 
dynamics in living cells. This combinatorial reporter concept can readily be transferred to other cell 
models and contexts to address specific physiological mechanisms.
Mitochondria are energetic and metabolic headquarters in the cell. This role is tightly associated with 
their tasks as stress sensors and mediators in processes such as adaptation, autophagy, and cell death1–3. 
The ability to control and maintain mitochondrial biomass and functional quality is therefore essen-
tial in cell (patho)physiology, and has been linked to conditions such as diabetes, neurodegeneration 
and cancer4. Adjustments, or defects, in mitochondrial functions are often accompanied by changes in 
organelle biomass and morphology (i.e. mitochondrial dynamics) (reviewed in5,6). To this end, mito-
chondrial biogenesis is crucial to prevent cellular stress by balancing changes in energy demand and 
replenishing damaged mitochondria7. In order to understand more about the physiological cues con-
trolling context-dependent mitochondrial adjustments, we need methods that integrate regulatory and 
structural aspects of these organelles in living cells. In the present study we combined genetic reporter 
tools to monitor transcriptional activity with organelle-specific localisation of the fluorescent reporter 
protein, to simultaneously assess mitochondrial biogenesis and morphology. This proved to be a prom-
ising conceptual strategy to study mitochondrial adaptations in living cells.
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The mitochondrion is a double membrane organelle that contains multiple copies of a small circular 
DNA molecule (mtDNA). These organelles house many metabolic pathways, both catabolic and anabolic, 
and account for a major part of the cellular ATP production via oxidative phosphorylation (OXPHOS) 
(6and references therein). In the OXPHOS process, the mitochondrial membrane potential is created by 
transmembrane proton transport from the matrix compartment, driven by electron transport through 
the OXPHOS protein complexes I–IV. Subsequently, reverse proton flow powers ATP synthesis by the 
action of ATP synthase (OXPHOS complex V). Complex IV consumes molecular oxygen as terminal 
electron acceptor (i.e. mitochondrial respiration), and analysis of oxygen consumption can therefore be 
used to measure OXPHOS rates (e.g.8,9). The standard conception is that rates of mitochondrial respi-
ration correlate with the amount of mitochondrial biomass in the cell; however, mitochondrial integrity 
and respiratory function may change depending on cellular conditions and incidents. Such effects may 
also involve characteristic changes in mitochondrial morphology and dynamics5.
The functional purpose of mitochondrial biogenesis is to maintain mitochondrial quality and secure 
sufficient ATP production10,11. Gene transcription and mtDNA replication are crucial in this process, 
to provide building blocks for new mitochondria. Crosstalk between the nuclear and mitochondrial 
genomes is therefore required to coordinate the synthesis of new organelles12,13. The transcription fac-
tor nuclear respiratory factor 1 (NRF-1) is essential in this regard, since it regulates the expression of 
multiple mitochondrial proteins encoded by nuclear genes. NRF-1 was initially characterised as an acti-
vator of cytochrome c expression14, and was subsequently found to regulate expression of additional 
OXPHOS subunits (reviewed in15). NRF-1 is now established as a master regulator of mitochondrial 
biogenesis (reviewed in6). One of the major routes of NRF-1 activation is via the cellular energy sen-
sor AMP-activated protein kinase (AMPK) (reviewed in16). AMPK is activated by increased levels of 
AMP, i.e. energy depletion, and leads to expression of the peroxisome proliferator-activated recep-
tor γ coactivator-1α (PGC-1α), which co-activates NRF-117. This results in transactivation of NRF-1 
target genes, including mitochondrial transcription factor A (TFAM)18. Activation of AMPK with 
5-amino-1-β -D-ribofuranosyl-imidazole-4-carboxamide (AICAR) is known to stimulate mitochondrial 
biogenesis in many cell types, including HeLa cells19–21. AICAR acts by trigging phosphorylation of 
AMPK22, which typically leads to activation of energy yielding processes, and inhibition of energy requir-
ing processes, in the cell16.
Fluorescence microscopy and quantitative image analysis represent important tools in mitochondrial 
research6,23. Mitochondria are then visualised in intact/living cells using chemical probes or expression of 
mitochondria targeted fluorescent proteins (e.g. GFP). Following image acquisition, quantitative analysis 
facilitates extraction of multiple mitochondrial parameters in 2 or 3 dimensions (2D, 3D), depending on 
the specimen/cell type24,25. In the present study, we imaged mitochondria in cells expressing GFP with a 
mitochondrial localisation sequence (mitoGFP) as a reporter for NRF-1 activity. The reporter construct 
was produced by combining the promoter region of an already established NRF-1 luciferase reporter26 
with the gene for mitoGFP. As mitoGFP (and not luciferase) can be detected in living cells, this approach 
fulfilled the objective to enable real-time studies of mitochondrial regulation in living cells. In conclu-
sion, we developed a novel live-cell reporter system for simultaneous analysis of AMPK/NRF-1-regulated 
gene transcription, and the subsequent effects on mitochondrial biomass and morphology.
Results
Generation of stable NRF-1 reporter cells with dynamic expression of mitoGFP. In order to 
establish a live-cell reporter system for assessment of mitochondrial biogenesis and morphology (Fig. 1A), 
we made a genetic reporter construct (NRF1mitoGFP) expressing mitochondrial targeted GFP under the 
control of a NRF-1 regulated promoter (Fig. 1B). Based on the knowledge that AMPK induces mitochon-
drial biogenesis via activation of NRF-127, the AMPK activator AICAR was used to induce reporter activ-
ity. The construct was stably inserted into HeLa cells by retroviral transduction, and cells that responded 
to AICAR treatment by expressing high mitoGFP intensity were sorted (Fig. 1C). After clonal expansion, 
each clone were tested by repeated stimulation (AICAR) - rest cycles, followed by sorting of cells with 
high and low mitoGFP intensities, respectively. In additional experiments, sub-populations of responding 
cells were isolated instead of single cells (data not shown). These sub-populations reported similar data 
as the isolated clones, which confirms that this reporter also may be employed without clonal isolation. 
Cells with an identical reporter construct lacking the NRF-1 response element (-66mitoGFP) did not 
demonstrate AICAR-dependent mitoGFP expression (data not shown). We isolated four clones demon-
strating sustainable and reproducible AMPK/NRF-1 regulated response depending on the presence of 
AICAR; one of these was selected for further validation and characterisation of mitochondrial dynamics. 
This clone is referred to as HeLaNRF1/c4. Microscopy confirmed that the mitoGFP colocalised with 
MitoTracker Deep Red in the mitochondrial network (Fig. 1D). The mitoGFP fluorescence was found to 
distribute evenly throughout the mitochondrial compartment, which is a crucial advantage for fluores-
cence-based image analysis of mitochondrial shape.
Markers of mitochondrial biogenesis. In order to confirm that AICAR activates AMPK in the 
HeLaNRF1/c4 cells, we analysed phosphorylation of AMPK and its downstream target acetyl-CoA car-
boxylase (ACC) by western blotting. Phosphorylation of both AMPK and ACC was initiated already after 
two minutes of AICAR treatment, and increased after 5 and 10 minutes (Fig. 2A). The phosphorylation 
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Figure 1. The live-cell mitochondrial reporter model. (A) Overview of the live-cell mitochondrial 
reporter model. A reporter construct (NRF1mitoGFP) with mitoGFP under the control of a promoter with 
NRF-1 responsive elements (R.E.) was inserted in HeLa cells. AICAR was used to trigger NRF-1 reporter 
activity, via AMPK. The cellular expression of mitoGFP (intensity) reflected transcriptional responses 
of mitochondrial biogenesis, whereas the mitochondrial localisation of the mitoGFP protein enabled 
quantitative image analysis of mitochondrial morphology and biomass. (B) NRF1mitoGFP construct map. 
(C) Establishment of reporter cells. Flow cytometry was used to sort responding cells based on mitoGFP 
expression, depending on the presence of AICAR. The figure shows the stepwise strategy to isolate cells with 
inducible and reversible mitoGFP expression after treatment with AICAR (0.5 mM). The red gates in the two 
dot plots show the sorted populations. The histogram shows how the mitoGFP intensity shifted from high 
(red curve) to low (green curve) when AICAR was removed from the reporter cells. (D) Colocalisation of 
mitoGFP and MitoTracker Deep Red (MTDR) in HeLaNRF1/c4 cells after 6 days treatment with AICAR 
(0.5 mM). The images show contrast corrected maximum intensity composites (MICs) of a representative cell 
(imaged on a Zeiss LSM 510 META confocal microscope).
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was blocked by the presence of the specific AMPK inhibitor, Compound C. To document that AMPK 
activation induced NRF-1-regulated mitochondrial biogenesis in these reporter cells, we measured 
the mRNA levels of NRF-1 and two of its target genes, cytochrome c oxidase (COX) and TFAM, in a 
time-lapse experiment (Fig. 2B). Following an initial decline in all mRNAs compared to control (24h), the 
levels steadily increased during the period of 2–6 days. In parallel measurements, the amount of mtDNA 
relative to nuclear DNA (i.e. mtDNA copy number) increased in accordance with the other markers of 
mitochondrial biogenesis (Fig.  2C). The effects of AICAR on gene expression and mtDNA coincided 
with a corresponding increase in mitoGFP expression in the reporter cells (Fig.  2D). A dose-response 
experiment showed that 0.5 mM AICAR gave maximum mitoGFP response in the reporter cells, and 
was well tolerated (Fig.  2E). These data confirm that AICAR triggers the normal response of AMPK/
NRF-1-regulated mitochondrial biogenesis, and that mitoGFP expression reports the activation status of 
AMPK/NRF-1-regulated mitochondrial biogenesis in the HeLaNRF1/c4 reporter cells.
Quantitative image analysis of mitochondria in single cells. Confocal microscopy and 
image-based mitochondrial analysis25 was used to quantify effects of AMPK/NRF-1 activation on mito-
chondrial biomass and morphology in the HeLaNRF1/c4 reporter cells. The z-stacks acquired by confo-
cal microscopy were processed and segmented for single cell analysis (Fig. 3). The data demonstrated that 
Figure 2. Biochemical markers of mitochondrial biogenesis in the reporter cells. (A) AMPK activation 
in HeLaNRF1/c4 cells. The cells were treated with 0.5 mM AICAR for 2, 5 or 10 min, with or without the 
AMPK inhibitor Compound C (10 μ M). The levels of phosphorylated AMPK (pAMPK) and ACC (pACC) 
were analysed by western blotting. (B) The effect of AICAR (0.5 mM) on expression of NRF-1, TFAM and 
COX was measured at four different time points (1, 2, 3 and 6 days), by quantitative PCR. The data were 
calculated relative to the untreated control (Ctr) and are shown as mean ± S.D. of two experiments with 
triplicate measurements. (C) The amount of mtDNA relative to nuclear DNA (mtDNA copy number) was 
measured by quantitative PCR, in cells grown for 1, 2, 3 or 6 days in presence of AICAR (0.5 mM). The 
data were calculated relative to untreated control (Ctr), and are shown as mean ± S.D. of three experiments 
with triplicate measurements. (D) Kinetics of mitoGFP induction. The expression of mitoGFP was measured 
by flow cytometry at different time points during 6 days of treatment with AICAR (0.5 mM). The data 
represents mean ± S.D. of three experiments (10 000 cells per sample), calculated relative to untreated cells. 
(E) Dose-response of AICAR in HeLaNRF1/c4 cells. The cells were treated with increasing concentrations 
of AICAR for 6 days and mitoGFP was detected by flow cytometry (10 000 cells per sample). The data 
represent mean ± S.D. of n ≥ 3. *p < 0.05; (C) compared with day 1, ANOVA test with Tukey’s multiple 
comparisons test; (D,E) compared with Ctr, Student’s t-Test.
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the AICAR-treated cells had significantly increased level of mitochondrial fluorescence from mitoGFP 
(Fig. 4A), and this coincided with increased cellular quantities of mitochondrial volume (Vm,cell), surface 
area (Sm,cell), and number (Ncell) (Fig. 4B–D). A minor fraction of the AICAR-treated cells had relatively 
low scores of mitoGFP and mitochondrial volume, most likely representing a small sub-population of 
non-responding cells which was also observed by flow cytometry (data not shown). Regression analysis 
revealed a strong correlation between the cellular mitoGFP intensity and Vm,cell, which was equivalent (i.e. 
the slope) in control and AICAR-treated cells (Fig. 4E). This observation warrants the use of total cell 
mitoGFP fluorescence (e.g. by flow cytometry) as a readout for mitochondrial biomass in these reporter 
cells. To study possible effects on the filamentous character of the mitochondria in these cells, we meas-
ured the Feret Ratio (FR), which is the ratio between the object length and width. The data demonstrated 
a small, but significant increase in the mean FR in AICAR-treated cells, indicating that the filamentous 
character is strengthened. Furthermore, a morphological change was substantiated by the change in the 
correlation between Sm,cell and Vm,cell (Fig.  4G) in the AICAR-treated cells. The increased slope of the 
regression line demonstrated a shift towards more surface area per volume, which corresponds well with 
extension of filamentous structures.
Quantitative image analysis of mitochondrial morphology. Based on effects on the cellular 
level in the AICAR-treated reporter cells, we analysed single mitochondria to identify and character-
ise the properties of mitochondrial subpopulations. In these studies, we included treatment with the 
Figure 3. Quantitative 3D image analysis of mitochondrial morphology. (A) Image processing and 
analysis was performed essentially as described previously25. The illustration gives an overview over the 
individual steps of the procedure. Background correction was performed on the unprocessed confocal 
z-stacks (RAW), by subtracting a fixed intensity decided from non-mitochondrial areas. Following 3D blind 
deconvolution, individual cells were segmented manually to enable single-cell analysis. The resulting z-stacks 
were processed by the 3D open filter, and loaded into the 3D module for analysis. The isosurface created in 
this process was applied as mask for measurement of mitoGFP intensity in the mitochondrial compartment, 
in the respective z-stacks not processed by the 3D open filter. B) Mitochondria imaged in untreated (Ctr) 
and AICAR-treated HeLaNRF1/c4 cells. The left-hand images show 2D maximum intensity composites 
(MICs) of the processed z-stacks from two representative cells. The centre images show the same cells in 3D, 
based on mitoGFP from all the z-stack section. The right-hand images show the mitochondrial isosurface, 
which was created to segment and analyse the mitochondria.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:17217 | DOI: 10.1038/srep17217
mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP), to characterise the effects 
of mitochondrial fragmentation on the analytical output28. From these experiments, we first selected 
the confocal z-stacks from three cells with distinct mitochondrial morphologies, namely filamentous, 
fragmented and apoptotic (Fig.  5A). The data from these cells were employed to establish a strategy 
to analyse mitochondrial subpopulations based on single organelle volume (Vm) and elongation (FR) 
(Fig.  5A,B). The following two types of subpopulation classification were defined: I) size-populations 
(small, Vm = 0.05–2 μ m3; medium size Vm = 2–10 μ m3; large, Vm > 10 μ m3), and II) shape-populations 
(spherical/swollen, FR = 1–3; elongated, FR = 3–4; filamentous, FR > 4). Accordingly, the cell with fila-
mentous mitochondria contained relatively few organelles, with a dominant compartment constituting 
most of the mitochondrial volume in the cell (Fig. 5B). In contrast, the cell with fragmented mitochon-
dria contained significantly increased number of organelles, particularly in the population of small mito-
chondria. This was similar in the apoptotic cell; however, this cell had an increased fraction of spherical 
or swollen mitochondria compared to the other two (Fig. 5C). These data were in accordance with the 
visual characterization of the mitochondria, and confirmed that this method is adequate for assessing 
different types of mitochondrial morphology in a quantitative manner. The subsequent analysis of the 
entire dataset revealed that AICAR-treated cells had a modest, but significant, reduction in mitochon-
drial number relative to total biomass (Ncell/Vm,cell) (Fig.  6A). Treatment with CCCP induced a major 
increase in mitochondrial number in both control and AICAR-treated cells. Further subpopulation anal-
ysis showed that AICAR treatment decreased the relative fractions of small and medium size organelles, 
whereas the fraction of large organelles was increased (Fig. 6B). Treatment with CCCP clearly increased 
the fraction of small and medium sized organelles, and reduced the fraction of large mitochondria, which 
Figure 4. Quantitative analysis of mitochondrial biomass in single cells. Confocal microscopy, and 
quantitative image analysis of mitoGFP was performed on untreated (Ctr) and AICAR-treated (0.5 mM, 6 
days) HeLaNRF1/c4 cells. Data were extracted from analysis of single cells (Ctr, n = 69; AICAR, n = 62) and 
are shown as and mean ± SEM. (A) Total mitoGFP intensity in the mitochondrial compartment, represented 
by the Integrated Optical Density (IOD). (B) Mitochondrial volume per cell (Vm,cell). (C) Mitochondrial 
surface area per cell (Sm,cell). (D) Number of mitochondrial objects per cell (Ncell). (E) Linear regression 
analysis of Vm,cell vs mitoGFP. Each dot represents a single cell. (F) Average Feret ratio (FR) of mitochondrial 
objects. (G) Linear regression analysis of Vm,cell vs Sm,cell. *p < 0.0001 compared with Ctr.
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is in accordance with mitochondrial fragmentation. Apparently, the effects of CCCP were reduced in the 
AICAR-treated cells compared to control cells. Furthermore, the AICAR-treated cells had an increased 
subpopulation of filamentous mitochondria, whereas the fraction of spherical and elongated organelles 
were reduced (Fig.  6C). Interestingly, CCCP caused a significant decrease in the fraction of spherical 
Figure 5. Assessment of mitochondrial morphology. HeLaNRF1/c4 cells were treated with CCCP (5 μ M, 
30–60 min) to induce mitochondrial fragmentation. Mitochondrial fragmentation was observed in most 
cells, and some cells (very few) showed signs of apoptotic mitochondrial morphology. (A) Three cells with 
similar amount of mitochondrial biomass (Vm,cell), but with distinct mitochondrial morphologies, were 
selected to characterize the different mitochondrial subpopulations. The three types of morphology are 
shown as “filamentous”, “fragmented”, and “apoptotic”. The upper images show contrast enhanced projections 
(mitoGFP, MIC) of the z-stacks, with the surface of the respective 3D-segmented mitochondrial objects 
underneath. (B) Frequency distribution analysis based on Vm. The following mitochondrial subpopulations 
were defined: “small”, Vm = 0.05–2 μ m3; “medium size” Vm = 2–10 μ m3; “large”, Vm > 10 μ m3. The gates of the 
“small” and “large” subpopulations are shown in the diagram. (C) Frequency distribution analysis based on 
Feret ratio (FR). The following mitochondrial subpopulations were defined: “spherical/swollen”, FR = 1–3; 
“elongated”, FR = 3–4; “filamentous”, FR > 4). The gates of the “spherical/swollen” and “filamentous” 
subpopulations are shown in the diagram.
www.nature.com/scientificreports/
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mitochondria, accompanied by an increase in filamentous organelles, exclusively in the AICAR-treated 
cells. This is probably explained by the findings that these cells have a more extensive filamentous net-
work, which may produce a larger relative quantity of filamentous mitochondrial fragments which 
dilute the subpopulation of spherical mitochondria, as observed in these data. In summary, these data 
demonstrate that AICAR-treatment strengthen filamentous network characters of the mitochondria, and 
reduces the amount of small organelles. Furthermore, this seems to mediate protective effects on the 
morphological changes caused by CCCP.
OXPHOS protein expression and function. To determine if activation of AMPK/NRF-1-regulated 
mitochondrial biogenesis includes expression of OXPHOS machinery in the HeLaNRF1/c4 reporter cells, 
we measured selected subunits by western blotting after treatment with AICAR (Fig. 7A). Densiometric 
quantification of the immunoblots showed increased expression of the subunits of OXPHOS complex 
III, IV and V (ATP synthase) (Fig. 7B). The expression of complex I tended to increase, but this was not 
statistically significant. In an additional experiment, the effects on OXPHOS expression were equal in the 
HeLaNRF1/c4 reporter cells compared with non-modified HeLa cells, after treatment with AICAR (data 
not shown). This confirmed that the reporter cells have conserved the original physiological response.
To evaluate how the increase in mitochondrial biomass and OXPHOS machinery affects the bio-



































































































































































































Figure 6. Quantitative analysis of mitochondrial dynamics. Untreated (Ctr) and AICAR-treated (0.5 mM, 
6 days) HeLaNRF1/c4 cells were imaged as described in Fig. 4. CCCP (5 μ M, 30–60 min) was added to 
induce mitochondrial fragmentation. Data were extracted from analysis of single cells and are shown as 
and mean ± SEM. (A) Number of mitochondria relative to biomass (Ncell/Vm,cell ratio). The number of 
cells analysed for each treatment is shown. (B) The relative amount (percentage) of the mitochondrial 
biomass (volume) found in the three different size-populations. (C) The relative number (percentage) of 
the mitochondria found in the three different shape-populations. *p < 0.05 compared with Ctr, #p < 0.05 
compared with Ctr+ CCCP.
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gradual increase in cellular TMRM was observed in the AICAR-treated cells during the three days of 
the experiment (Fig. 7C). This effect is most likely due to increased mitochondrial biomass in the treated 
cells, and not hyperpolarisation of the membrane potential. Oxygen consumption measurements con-
firmed that the treated cells had a significantly increased mitochondrial respiration (40%) (Fig.  7D,E). 
Subsequent injection of oligomycin (ATP synthase inhibitor) and FCCP (uncoupler) confirmed that 
membrane integrity and respiratory control were intact. The maximal rate of the electron transport 
system, determined after complete uncoupling with FCCP, showed a tendency of increased respiratory 
capacity, however, this effect was not statistically significant. Mitochondrial respiration was primarily 
driven by OXPHOS complex I, since addition of rotenone, an inhibitor of this complex, nearly eliminated 
oxygen consumption. In summary, induction of mitochondrial biogenesis was associated with stimula-
tion of mitochondrial respiration under normal cell culture conditions.
Reversion of mitochondrial adaptations. In order to evaluate the physiological relevance of our 
reporter model it was important to determine if the responses were reversible when the stimulus (AICAR) 
was withdrawn. We therefore treated the cells for 6 days with AICAR, and then changed to medium 
without AICAR for 6 days. Treatment with AICAR reduced cell proliferation (Fig.  6A), which agrees 
with engagement of energy-saving programs controlled by AMPK16. Subsequent removal of AICAR led 
to re-establishment of cell growth, which confirms that the physiological adaptations were reversible. 
Correspondingly, the AICAR-induced increase in mitoGFP (Fig.  8B) and mtDNA (Fig.  8C) reversed 
Figure 7. Mitochondrial respiration. (A) Western blot analysis of OXPHOS proteins of complex I–V 
(CI-V), in HeLaNRF1/c4 cells treated with 0.5 mM AICAR for 24 hours or 6 days. The shown blots are 
representative for three independent experiments. (B) Data quantified from the immunoblots (in A). Protein 
expression levels (normalised to β -actin) were calculated relative to untreated control (Ctr) and are shown as 
mean ± S.D. of three experiments. (C) Mitochondrial membrane potential was studied using the fluorescent 
probe TMRM, after 1, 2 and 3 days of treatment with AICAR (0.5 mM). The data represents mean ± S.D. of 
three experiments (10 000 cells per sample). (D,E) Oxygen consumption rates in HeLaNRF1/c4 cells after 
treatment with AICAR (0.5 mM, 6 days). (D) The diagram shows a representative experiment. (E) Data 
analysis of routine (basal) respiration rate (ROUT), uncoupled respiration (LEAK), respiratory capacity 
(ETS), and rotenone insensitive respiration (ETSrot). Data are presented as mean ± S.D. of five experiments. 
*p < 0.05 comparing AICAR-treated cells with Ctr.
www.nature.com/scientificreports/
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when the treatment was terminated. The effects on mitoGFP and mtDNA were similar in magnitude and 
kinetics; however, the maximum mtDNA level was seen 2 days after end of treatment, and later than for 
mitoGFP. The delay is most likely explained by the fact that mtDNA replication occurs downstream of 
transcriptional regulation, which is reported by mitoGFP. Both mitoGFP and mtDNA had returned to 
normal levels 6 days after ending the treatment. Hence, these data suggest the half-life of AICAR-induced 
mitoGFP is approximately 3 days under these conditions. In summary, this experiment confirms that 
the cellular and mitochondrial effects of AICAR are reversible, and that the level of mitoGFP reports a 
relevant and valid measure of mitochondrial biogenesis.
Discussion
The presented work describes a new GFP-based reporter approach for multifaceted studies of mitochon-
drial regulation in living/intact cells. The method enabled surveillance of the AMPK/NRF-1–controlled 
program of mitochondrial biogenesis, simultaneous with quantitative analysis of mitochondrial biomass 
and morphology. Expression of the mitoGFP reporter was activated with AICAR, and correlated with 
markers of NRF-1 transactivation and mitochondrial biogenesis, both in magnitude and kinetics (1.5–2 
fold after 6 days). Confocal microscopy and quantitative 3D image analysis confirmed correspond-
ing effects on mitochondrial biomass and morphology. The induction of mitochondrial biogenesis via 
AMPK/NRF-1 was reversible and compatible with long term cell survival.
Based on the presented results, the NRF1mitoGFP reporter plasmid was found to facilitate simulta-
neous analysis of NRF-1 activity and mitochondrial morphology in intact/living cells. The construct was 
stably inserted into HeLa cells, and clones (or populations) that demonstrated robust and reproducible 
reporter activity were isolated. Indeed, this was found to be a successful strategy to study the tuneable 
mechanisms of mitochondrial regulation targeted in this study. Throughout the work, it was essential to 
minimise potential undesirable effects that could mask the output, e.g. toxic stress and cell death. Such 
effects may be caused by the treatment of interest (e.g. AICAR19,29,30), or by intracellular GFP accumu-
lation31. Hence, the experimental conditions were established to enable long-term cell survival under 
repetitive stimulation/rest cycles. The subsequent analyses of cellular and mitochondrial properties con-
firmed that the cellular conditions and responses were of physiological relevance.
The ability of AICAR to activate AMPK, and thereby induce mitochondrial biogenesis in HeLa cells 
was an important condition of the present study. AICAR is known to induce phosphorylation of AMPK 
in an LKB1- independent manner in these cells22. In accordance with previous findings32,33 our data 
showed that AICAR activated AMPK by phosphorylation within minutes. This was accompanied by 
phosphorylation of ACC, which is frequently used as a marker of AMPK activity16. The subsequent 
response was a general reduction in gene transcription, which is consistent with induction of energy 
stress and activation of AMPK16. However, this effect was transient, and after the first 24 hours all mark-
ers of mitochondrial biogenesis continuously increased during the period of 6 days. Consequently, we 
observed increased levels of several protein subunits of the OXPHOS machinery, as well as increased 
rate of mitochondrial respiration. The amplification of mtDNA coincided with increased expression of 
Figure 8. Mitochondrial reversion after withdrawal of AICAR. HeLaNRF1/c4 cells were cultured in 
presence of AICAR (0.5 mM) for 6 days, followed by a subsequent period (6 days) in absence of AICAR. 
Samples were collected and analysed every second day during the experimental period. (A) Proliferation 
was examined by cell counting. The data, calculated as percent of the untreated control cultures (Ctr), are 
shown as mean ± S.D. of three independent experiments. (B) The intensity of mitoGFP was detected by flow 
cytometry (10 000 cells/sample). The diagrams show the mitoGFP level relative to control as mean ± S.D. 
of three independent experiments. (C) mtDNA (copy number) determined by quantitative PCR. Data 
are presented as mean ± S.D. of six independent experiments with triplicate measurements. *p < 0.05; 
(A,B) compared with Ctr, Student’s t-Test; (C) compared with 8 days, ANOVA test with Tukey’s multiple 
comparisons test.
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TFAM, a regulator of mitochondrial transcription and mtDNA replication34,35. This was also accom-
panied by increased expression of NRF-1, which is known to control TFAM expression18. Thus, our 
data complements previous studies showing that AICAR activates AMPK and induces mitochondrial 
biogenesis via firmly established mechanisms in HeLa cells19,36, and confirms that these mechanisms are 
intact in the modified reporter cells. Hence, this provides rationale for using this mitoGFP-based reporter 
strategy to study mitochondrial mechanisms in living cells.
In cultured cells, fluorescence microscopy provides valuable opportunities to monitor both the 
amount and shape of mitochondria. Some cell types, such as cultured fibroblasts, may be analysed using 
2D image quantification methods24, but for cells of a certain thickness 3D volumetric measurements 
are preferred25. Here, expression of mitoGFP reporter protein in HeLa cells facilitated mitochondrial 
imaging by confocal microscopy, and subsequent 3D quantification of mitochondrial biomass and mor-
phology. Mitochondrial subpopulation analysis was established based on organelle size and shape. Our 
data demonstrated a close correlation between the cellular mitoGFP intensity and mitochondrial volume 
during treatment with AICAR. A continuum of filamentous structures forming a mitochondrial network 
(“reticulum”) accounted for the major fraction of the mitochondrial volume (~90% or more), in both 
treated and untreated cells. AICAR promoted expansion of the network, and reduced the relative amount 
of small organelles. Induction of mitochondrial fragmentation with CCCP increased the amounts of 
small organelles; however, the filamentous character remained stronger in the AICAR-treated cells. Thus, 
induction of mitochondrial biogenesis with AICAR was found to be associated with filament promoting 
and protecting effects on mitochondrial morphology.
In summary, these results provide proof of principle in support for the use of the presented mito-
chondrial reporter strategy to study integrated mechanisms of mitochondrial regulation and dynamics 
in the living cell. The results of the analysis adequately reflected effects on the innate machinery of mito-
chondrial biogenesis, as well as changes in mitochondrial biomass and morphology. We believe that the 
concepts of this work may provide useful tools to study integrated mechanisms of mitochondrial biology 
in a physiological context.
Methods
Cells and culture conditions. Phoenix A retroviral packaging cells (DR. Gary Nolan, Stanford 
University, USA) and HeLa cells (American Type Culture Collection, ATCC, Manassas, VA, USA) were 
maintained in DMEM supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml 
penicillin and 100 μ g/ml streptomycin (all from Sigma-Aldrich, St.Louis, MO, USA). Cells were kept in 
5% CO2 at 37 °C.
Cloning. The plasmids pGL3RC4/-6637 and pUHC 13-3 p4xNRF126 with luciferase reporter sequences 
were a kind gift from Professor Richard Scarpulla. The promoter cassettes of these plasmids were inserted 
into a pEGFPmito plasmid in order to generate corresponding plasmids with mitochondrial targeted 
GFP reporter sequence. The pEGFPmito plasmid was initially generated by exchanging EYFP in the 
commercially available pEYFP-mito vector (Clontech, BD Biosciences, Franklin Lakes, New Jersey, 
US) with EGFP. The fluorescent protein fragments from pEGFP-N1 (Clontech, BD Biosciences) and 
pEYFP-mito was excised using the restriction enzymes BamHI and BsrGI and the EGFP fragment was 
ligated into vector with the mitochondria targeting sequence.
The promoter region containing 4 repetitions (p4xNRF1) of the NRF-1 responsive element from 
rat cytochrome c promoter was excised from pUHC 13-3 p4xNRF1 using SacI and PstI, and ligated 
into pEGFPmito previously cut with NheI. A negative control plasmid that lacks the NRF-1 respon-
sive promoter region (-66mitoGFP) was constructed by excising the promoter from pGL3RC4/-66 with 
KpnI and NcoI. This fragment was then cloned into the pEGFPmito vector which was cut with NheI. 
Incompatible sticky ends were blunted when necessary. Correct orientation of the inserts was controlled 
using restriction enzymes HindII and NotI. All restriction enzymes in this study were purchased from 
Fermentas (Thermo Scientific, Waltham, MA, USA). The plasmids with correct promoter orientation 
were sequenced and tested in transient transfections, before cloned into the retroviral vector pTRA 
IRES-GFP38. The retroviral p4xNRF1 reporter construct was prepared using a blunt end-sticky end clon-
ing approach. The p4xNRF1mitoGFP plasmid was first cut with BSpEI, before it was blunt-ended and 
cleaved with NotI. The resulting fragment was cloned into pTRA IRES-GFP, which had been opened 
with XhoI and blunt-ended, followed by a fragment removal of the IRES-GFP with NotI. The RC4/-
66mitoGFP was cloned into the retroviral vector using XhoI-NotI restriction sites. The plasmids were 
sequenced to confirm correct insertion of reporter cassette. The resulting reporter plasmid is referred to 
as NRF1mitoGFP (Fig. 1B).
Retroviral transduction. To generate retroviruses expressing either the NRF1mitoGFP or -66mito-
GFP reporter constructs, Phoenix A packaging cells were transfected with the corresponding retroviral 
vector constructs by the calcium phosphate method39. At 6 hours post-transfection, the medium was 
replaced with fresh DMEM containing 10% FBS, and cells were cultured for 12 hours. The medium was 
then changed to the target cell medium, and the cells were grown for additionally 20 hours to produce 
retroviruses. Conditioned medium was collected and filtered through 0.45 μ m-pore-size polysulfonic 
filters. Samples of these supernatants were applied immediately to the cells to be transduced, which had 
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been trypsinised just prior to infection. Proteamine sulphate (Sigma, St. Louis, MO, USA) was added 
to the supernatant at a final concentration of 8 μ g/ml. The cells were spin-infected by centrifugation for 
90 minutes, using 1200 g and 37 °C. The cells were then incubated for 18 hours with the virus containing 
media. After infection, the cells were placed in fresh growth medium and cultured under routine con-
ditions. Four days after infection, GFP positive cells were sorted using the FACS Aria (FACS-ARIA, BD 
Biosciences, Franklin Lakes, NJ, USA). These cells were then grown in culture for 2 weeks before further 
experiments were initiated.
Establishment of inducible reporter cell clones. HeLa cells stably expressing the different reporter 
constructs were sorted for cells with low basal mitoGFP expression (FACS-ARIA) (Fig. 1C). These cells 
were further treated with 0.5 mM AICAR (Toronto Research Chemicals Inc., North York, ON, Canada) 
for 3 days, and cells showing high mitoGFP expression compared to untreated cells were sorted as sin-
gle cells (clones) or populations (sub-lines) in 96 well plates. Following culture expansion for 4 weeks 
in absence of AICAR, flow cytometry analysis (Accuri™ C6, BD Accuri Cytometers Inc., Ann Arbor, 
MI, USA) was performed and the cultures that had returned to basal mitoGFP levels of expression were 
selected. Finally, AICAR-dependent induction of mitoGFP expression was confirmed after treatment 
with 0.5 mM AICAR for 3 days, and the clones/sub-lines with the most significant response were chosen 
in further experiments. In this study clone 4, referred to as HeLaNRF1/c4, were used in all experiments.
Cell growth and treatment conditions for compound stimulation. For short term experiments 
(treatment up to 30 min), 0.4 × 106 cells were seeded in T75 flasks one day prior to stimulation. Cells 
for western blotting were lysed directly in the flask. For long term experiments (up to 12 days), various 
number of cells were seeded in T175 flasks, depending on the length of the experiment. The cells were 
allowed to attach 4 hours prior to stimulation. The medium was exchanged with fresh medium with 
treatment after 3 days. After the given time, the cells were trypsinised in 0.25% trypsin (37 °C), counted 
and GFP expression was analysed by flow cytometry (Accuri™  C6). For analysis of RNA, DNA or pro-
tein, the cells were washed two times with PBS and harvested by centrifugation. The pellets were stored 
at − 80 °C for later analysis.
Gene expression analysis. Total RNA was extracted from cells using RNAeasy kit (Qiagen, Hilden, 
Germany). The resulting amount of RNA was quantified using Nanodrop 1000 Spectrophotometer 
(Thermo Scientific). Reverse transcription was performed from 1 μ g total RNA using High-Capacity 
Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, US). Quantitative PCR was performed 
in the LightCycler 480 detection system (Roche, Basel, Switzerland) using the LightCycler 480 Probes 
master kit, and specific FAM probes and primers from Applied Biosystems: Nuclear respiratory fac-
tor 1; NRF-1, Hs00602161_m1, Transcriptional Factor A mitochondrial; TFAM, Hs01082775_m1 and 
Cytochrome C Oxidase; Cox4i, Hs00971639_m1. As control gene, we used 18S (RT-CKFT-18S) from 
Eurogentec (Liège, Belgium). Fold change was calculated by the Δ Δ Ct method40.
Mitochondrial DNA (mtDNA) copy number. Total cellular DNA was isolated using DNAeasy 
blood and tissue kit and Allprep DNA/RNA Mini kit (both from Qiagen). Specific primer/probe set 
for mtDNA, mitochondrially encoded NADH dehydrogenase 1, ND1 (Hs02596873_s1), was purchased 
from Applied Biosystems and nDNA primer 18S (RT-CKFT-18S) from Eurogentec. Quantitative PCR 
was carried out as above and the mtDNA:nDNA ratio was calculated40,41.
Western Blotting. Cells were washed in PBS and lysed in Ripa buffer with aprotinin (1 μ g/ml), leu-
peptin (1 μ g/ml), sodium vanadate (2 mM) and PMSF (1 mM) (all from Sigma-Aldrich). Protein concen-
trations were determined using BCA protein Assay (Pierce, Thermo Scientific). Proteins were separated 
by SDS-PAGE (10% gel), and blotted onto polyvinylidine difluoride (PVDF) membranes. The mem-
branes were blocked with 3% BSA-TBS-T (25 mM Tris-HCl, 1mM NaCl, and 0.1%Tween 20), followed by 
overnight incubation with primary antibody. We employed a cocktail of 5 monoclonal antibodies against 
OXPHOS components (MitoProfile® Total OXPHOS Human WB Antibody Cocktail; diluted 1:500), a 
complex II antibody (Complex II antibody cocktail; diluted 1:500) (both from Mitosciences, Eugene, OR, 
USA) and antibodies against p-AMPKα and p-ACC (diluted 1:1000, Cell Signaling Technology, Inc., 
Beverly, MA, USA). For loading control we used β -actin antibody (Sigma-Aldrich). After immunolabel-
ling, the membranes were washed in TBS-T and incubated with the appropriate secondary horse radish 
peroxidase (HRP)-conjugated antibody (Bio-Rad Laboratories, Inc., Hercules, Ca, USA). Detection was 
performed using the enhanced chemiluminescence kit (Bio-Rad) and the Luminescent Image analyser 
apparatus (Bio-Rad). Quantitative densiometric analysis of the immunoblot bands was performed using 
the Bio-Rad Image Lab software and the data were normalised to β -actin in each sample.
Mitochondrial respiration. Oxygen consumption rates were studied employing an Oxygraph O2K 
instrument and DatLab software (Oroboros Instruments, Innsbruck, Austria), as previously described8. 
Cells were harvested, and washed in PBS, and 2 × 106 cells were transferred to the 2.2 ml analytic cham-
ber with DMEM medium. Oxygen consumption rates were then continuously monitored after sequential 
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additions of malate (1.8 mM)/glutamate (9.1 mM), oligomycin (1.8 μ g/ml), carbonylcyanide-4-(trifluo-
romethoxy)-phenylhydrazone (FCCP, titration to maximum activity; 0.11 μ M per addition), succinate 
(9.1 mM)/digitonin (4.5 mg/ml, 2.5 mg per mill cells), rotenone (0.5 μ M), and antimycin A (2.3 μ M). 
Antimycin A resistant oxygen consumption was subtracted as background.
Mitochondrial membrane potential. The cells were stained in 200 nM tetramethylrhodamine 
methyl ester (TMRM; Invitrogen, Carlsbad, CA, USA) for 30 minutes at 37 °C. Analysis was performed 
by flow cytometry (Accuri™  C6, Ann Arbor, MI, USA).
Confocal microscopy and image analysis. For confirming mitochondrial localisation of mitoGFP, 
the cells were counterstained with MitoTracker Deep Red (Invitrogen). The cells were first seeded in 
35 mM petri dishes with 14 mM glass bottom microwell (MatTek Corporation, Ashland, MA, USA) and 
allowed to adhere for 4 hours (4000 cells/dish). They were then treated with 0.5 mM AICAR for 6 days. 
The medium (and treatment) was replaced after 3 days. MitoTracker Deep Red (200 nM) was used as 
described in the manufacturer’s protocol. Images were acquired on a Zeiss LSM 510 META confocal 
microscope (Carl Zeiss, Oberkochen, Germany).
For quantitative 3D image analysis of mitochondrial biomass and morphology, cells were seeded 
(0.2 × 106 cells/T75 flask) and allowed to adhere overnight. They were then treated with 0.5 mM AICAR 
for 6 days; including medium and treatment replacement after 3 days. On day 5, the cells were reseeded 
to a suitable density (0.5–1 × 105 cells/chamber) in microscopy chamber slides (Lab-Tek™ II Chamber 
Slides, 2 or 4 chambers/slide, Thermo Scientific). The original medium was collected before the cells 
were trypsinised (0.25% trypsin, 37 °C), and transferred to the corresponding reseeded cultures. On day 
6, the medium was replaced with microscopy medium (pH7.4) consisting of DMEM (phenolred-free) 
supplemented with 10 mM glucose, 2 mM l-glutamine, 2 mM sodium pyruvate and 5 mM HEPES (all 
from Sigma). Control cells were cultured without the presence of AICAR. For the mitochondrial frag-
mentation analysis CCCP (final concentration of 5 μ M) was added 30–60 min before imaging.
Confocal microscopy of mitoGFP was performed on a Zeiss LSM 510 META confocal micro-
scope using a Plan-Apochromat 63 × 1.40 NA oil objective. Image acquisition, processing and analysis 
were performed essentially as described thoroughly in25, using the Image-Pro Plus software (version 
7.0) (Media Cybernetics, Inc., Washington, USA). An illustration of the consecutive steps is shown in 
Fig.  3A. The acquired 12 bit z-stacks were background corrected (fixed level within each experiment), 
and processed by 3D blind deconvolution. In order to enable single cell analysis, each z-stack, which in 
general contained 2–5 cells, was manually masked to produce z-stacks with single cells. These z-stacks 
were processed with the 3D open filter (x, y, z: 3, 3, 3), followed by loading into the 3D module of the 
software. Volumetric models of the mitochondria were constructed using no subsampling or simplifica-
tion settings. The surface level was fixed for the experiments in this study. Objects larger than 0.05 μ m3 
were accounted as mitochondrial objects. For measurement of mitoGFP intensity in the mitochondrial 
compartment, the 3D isosurface created from the processed z-stacks were applied as mask on the corre-
sponding z-stacks that had not been processed by the 3D open filter.
Statistical analysis. Statistical analysis was performed using a standard two-sided Student’s t-Test 
(where not indicated otherwise), and one-way ANOVA with Tukey’s multiple comparisons test. 
Differences with p < 0.05 were considered as significantly different. Three individual experiments were 
performed if not indicated otherwise.
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